Egetis Therapeutics AB (publ) (STO:EGTX)
Sweden
· Delayed Price · Currency is SEK 3.650
-0.185 (-4.82%)
May 13, 2025, 5:29 PM CET
Egetis Therapeutics AB Market Cap
Egetis Therapeutics AB has a market cap or net worth of 1.31 billion as of May 13, 2025. Its market cap has decreased by -28.64% in one year.
Market Cap
1.31B
Enterprise Value
1.14B
Revenue
46.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.65
Market Cap Chart
Since April 7, 2011, Egetis Therapeutics AB's market cap has increased from 224.89M to 1.31B, an increase of 483.05%. That is a compound annual growth rate of 13.31%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 102.97B |
| Sectra AB | 59.53B |
| Getinge AB | 52.98B |
| Camurus AB | 36.97B |
| Medicover AB | 36.18B |
| AddLife AB | 22.95B |
| Vitrolife AB | 21.41B |
| Vimian Group AB | 20.31B |